Home Healthcare Biotechnology RNA Therapeutics Market

RNA Therapeutics Market Size, Share & Trends Analysis Report By Therapy Type (mRNA Therapeutics, RNA interference (RNAi), Antisense oligonucleotides, Others), By Application (Oncology, Infectious Diseases, Genetic Diseases, Ophthalmology, Cardiovascular Diseases, Others), By End User (Hospitals & Clinics, Research Institutes, Others) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 09, 2026 | Author: Dhanashri B | Format: | Report Code: SR7208DR | Pages: 145
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. RNA Therapeutics Market Size Analysis
    1. Introduction
    2. RNA Therapeutics Market Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
      1. mRNA Therapeutics
      2. RNA interference (RNAi)
      3. Antisense oligonucleotides
      4. Others
    3. RNA Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Genetic Diseases
      4. Ophthalmology
      5. Cardiovascular Diseases
      6. Others
    4. RNA Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research Institutes
      3. Others
  7. North America RNA Therapeutics Market Size Analysis
    1. Introduction
    2. RNA Therapeutics Market Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
      1. mRNA Therapeutics
      2. RNA interference (RNAi)
      3. Antisense oligonucleotides
      4. Others
    3. RNA Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Genetic Diseases
      4. Ophthalmology
      5. Cardiovascular Diseases
      6. Others
    4. RNA Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research Institutes
      3. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
  8. Europe RNA Therapeutics Market Size Analysis
    1. Introduction
    2. RNA Therapeutics Market Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
      1. mRNA Therapeutics
      2. RNA interference (RNAi)
      3. Antisense oligonucleotides
      4. Others
    3. RNA Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Genetic Diseases
      4. Ophthalmology
      5. Cardiovascular Diseases
      6. Others
    4. RNA Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research Institutes
      3. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
  9. APAC RNA Therapeutics Market Size Analysis
    1. Introduction
    2. RNA Therapeutics Market Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
      1. mRNA Therapeutics
      2. RNA interference (RNAi)
      3. Antisense oligonucleotides
      4. Others
    3. RNA Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Genetic Diseases
      4. Ophthalmology
      5. Cardiovascular Diseases
      6. Others
    4. RNA Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research Institutes
      3. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
  10. Middle East and Africa RNA Therapeutics Market Size Analysis
    1. Introduction
    2. RNA Therapeutics Market Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
      1. mRNA Therapeutics
      2. RNA interference (RNAi)
      3. Antisense oligonucleotides
      4. Others
    3. RNA Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Genetic Diseases
      4. Ophthalmology
      5. Cardiovascular Diseases
      6. Others
    4. RNA Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research Institutes
      3. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
  11. LATAM RNA Therapeutics Market Size Analysis
    1. Introduction
    2. RNA Therapeutics Market Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
      1. mRNA Therapeutics
      2. RNA interference (RNAi)
      3. Antisense oligonucleotides
      4. Others
    3. RNA Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Genetic Diseases
      4. Ophthalmology
      5. Cardiovascular Diseases
      6. Others
    4. RNA Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research Institutes
      3. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. mRNA Therapeutics
        2. RNA interference (RNAi)
        3. Antisense oligonucleotides
        4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Genetic Diseases
        4. Ophthalmology
        5. Cardiovascular Diseases
        6. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Institutes
        3. Others
  12. Competitive Landscape
    1. RNA Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Moderna, Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Pfizer Inc.
    3. Alnylam Pharmaceuticals, Inc.
    4. Ionis Pharmaceuticals, Inc.
    5. Sarepta Therapeutics, Inc.
    6. Novartis AG
    7. Sanofi
    8. CureVac N.V.
    9. Orna Therapeutics
    10. Arrowhead Pharmaceuticals, Inc.
    11. Suzhou Abogen Biosciences
    12. CSPC Pharmaceutical
    13. Dicerna Pharmaceuticals
    14. Geron
    15. Others
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.